Insider Trading History of Versant Side Fund Iv, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Versant Side Fund Iv, L.p. since 2019. This trader's CIK number is 1456591. At the time of last reporting, Versant Side Fund Iv, L.p. was the Officer of Tempest Therapeutics, Inc.. (stock ticker symbol TPST). Also see all insider trading activities at Tempest Therapeutics, Inc..

Note that in the past Versant Side Fund IV, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Oyster Point Pharma, Inc. (OYST) by Versant Side Fund Iv, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 OYST 0 $0 550,000 $8,174,650 0 $0
2019 OYST 590,000 $9,440,000 0 $0 0 $0

Yearly summary of insider trading at Tempest Therapeutics, Inc. (TPST) by Versant Side Fund Iv, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 TPST 0 $0 787,999 $967,186 0 $0


Insider trading activities at 2 companies by Versant Side Fund Iv, L.p.:

1. Oyster Point Pharma, Inc. (OYST)

2. Tempest Therapeutics, Inc. (TPST)

Table 1. Insider trading of Oyster Point Pharma, Inc. (OYST) by Versant Side Fund Iv, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-10-18 OYST Sale 550,000 14.86 8,174,650
2019-11-04 OYST Buy 590,000 16.00 9,440,000

Table 2. Insider trading of Tempest Therapeutics, Inc. (TPST) by Versant Side Fund Iv, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-12 TPST Sale 387,999 1.10 427,186
2024-08-08 TPST Sale 400,000 1.35 540,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Versant Side Fund Iv, L.p. (Officer of Tempest Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.